Medicine News and Research

RSS

FDA recommends heart drug designed for blacks

The U.S. Food and Drug Administration have announced that a heart-failure drug manufactured for African-Americans significantly reduced deaths and hospitalizations and its side effects were similar to those of a placebo's.

16 Jun 2005

Aortic disease difficult to diagnose

Aortic disease kills nearly 15,000 people in the United States each year, but the rarity and complexity of this deadly disorder make accurately diagnosing it difficult for doctors in the health-care trenches, University of Florida researchers have found.

15 Jun 2005

First demonstration of a vaccine for Parkinson's

Researchers at the University of California, San Diego (UCSD) School of Medicine working with scientists at Elan Pharmaceuticals, have reported promising results in mice of a vaccine approach to treating Parkinson’s and similar diseases. These results appear in the June edition of the journal Neuron.

15 Jun 2005

Protocol used to treat the first known survivor of rabies without prior vaccination published

The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.

15 Jun 2005

Walking more slowly, obese individuals can burn more calories per mile and may reduce the risk of arthritis or joint injury

Leisurely walking for distance combined with low-impact cardiovascular activity appears to be the best formula for obese people seeking to get into shape and stay healthy, according to a University of Colorado at Boulder study.

15 Jun 2005

Report on Hispanics and genes, culture, and medicines highlights the rise of individualized medicine

"The FDA's review today of BiDil could make it the first drug approved specifically for African Americans and marks the end of 'one-size-fits-all' medicine," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health (the Alliance), the nation's leading Hispanic health advocacy group.

15 Jun 2005

Acute coronary syndrome patients at increased risk of stroke

Patients hospitalized with chest pain or heart attack symptoms are at an increased risk of stroke even after being discharged, according to a study published in Circulation: Journal of the American Heart Association.

15 Jun 2005

Abstinence education programs increased youth's support for abstinence

The initial findings from a one-year followup of 2,310 students participating in an evaluation of four abstinence-only education programs show that the programs increased support for abstinence.

15 Jun 2005

Spinal arthritis often overlooked in children

When kids or teens experience aching joints and stiffness it may be more than growing pains. It may be arthritis of the spine and other joints (ankylosing spondylitis), which researchers report can often go undiagnosed for years and years, leading to serious problems in adulthood.

15 Jun 2005

Heavy drinkers at risk of lasting brain damage sooner rather than later

Researchers at Saint Louis University have shown, in a new animal study, that chronic alcohol consumption produces memory loss and learning problems in very heavy drinkers much sooner than previously thought.

15 Jun 2005

Six new bird flu cases in Vietnam

Another six cases of bird flu have been reported in Vietnam, taking the total since December 2004 to 61. Of these 18 have died.

15 Jun 2005

Exposure to sunlight may decrease the risk of prostate cancer

In the largest such study to date, a research team from three cancer centers measured sunlight exposure in men and found that increased exposure to sunlight may decrease the risk of prostate cancer.

15 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

Holographic movies show promise for medical applications

In a small research laboratory at UT Southwestern Medical Center, a grainy, red movie of circling fighter jets emerges from a table-top black box, while nearby, a video of a rotating human heart hangs suspended in a tank of gooey gel.

14 Jun 2005

The most frequently used drugs for treating chronic insomnia have never been approved for that purpose

Vaughn McCall, M.D., M.S., professor and chairman of the Department of Psychiatry and Behavioral Medicine, told a special consensus panel at the National Institutes of Health (NIH) that he could find no evidence that randomized controlled clinical trials had ever been conducted for five of the 10 pharmaceuticals prescribed most often for chronic insomnia.

14 Jun 2005

Research urges a new approach to cancer detection

A few years ago, Medhat Osman, M.D., Ph.D., had a patient who was scanned due to a suspicion of lung cancer using positron emission tomography (PET) and computer tomography (CT) technology. The scan came back negative, but the patient then complained of a problem with his leg.

14 Jun 2005

Continuous drinking for as little as eight weeks affects learning and memory up to 12 weeks later

Rodent studies, for example, have shown that chronic alcohol consumption for six months or more can produce permanent deficits and neural damage. A rodent study in the June issue of Alcoholism: Clinical & Experimental Research is the first to show that continuous drinking for as little as eight weeks can produce deficits in learning and memory that last up to 12 weeks after drinking stopped.

14 Jun 2005

Two common gene variations are associated with the risk for developing chronic kidney disease

Two common gene variations are associated with the risk for developing chronic kidney disease, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions. One variant increases risk and the other decreases risk with a similar effect in whites, African-Americans, diabetic and non-diabetic individuals.

14 Jun 2005

Study reveals benefits of using insulin earlier

Results of an all-Canadian study announced June 13 at an international diabetes congress demonstrate that patients with type 2 diabetes can safely achieve target blood sugar (glycemic) levels faster and more frequently when insulin glargine (a basal, long-acting insulin) is added to therapy, versus using oral agents alone.

14 Jun 2005

Royal Pharmaceutical Society responds to over the counter medication report

Responding to the British Medical Association's (BMA) report, Over the counter medication, David Pruce, Director of Practice and Quality Improvement, the Royal Pharmaceutical Society of Great Britain, said:

14 Jun 2005